Staccato zaleplon: Phase I data

In a double-blind, placebo-controlled, U.S. Phase I trial in 40 healthy volunteers, doses of 0.5, 1, 2 and 4 mg of inhaled AZ-007 had acceptable pharmacokinetics and a median time to peak venous conce...